SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic ...
Hikers are risking their lives daily venturing into closed areas of a popular Canterbury national park track, where ...
Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. (Nasdaq: DNLI) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa.
Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty ...
The open-source platform for collaborative documentation reaches version 4.0 with a comment function, revised interface, and ...
Bucks head coach Doc Rivers spoke about trade rumors involving franchise star Giannis Antetokounmpo following a Wednesday ...
In a subsequent report, ESPN’s Brian Windhorst confirmed that Antetokounmpo wants out of Milwaukee. Windhorst added that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback